SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-010342
Filing Date
2022-05-19
Accepted
2022-05-19 16:31:09
Documents
13
Period of Report
2022-05-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20220519.htm   iXBRL 8-K 49707
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 13541
  Complete submission text file 0000950170-22-010342.txt   184432

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220519.xsd EX-101.SCH 2490
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220519_pre.xml EX-101.PRE 11025
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220519_lab.xml EX-101.LAB 13438
7 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220519_htm.xml XML 4673
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 22943449
SIC: 2834 Pharmaceutical Preparations